Knight Capitol Consultants
Campaign Finance
$35,250 Given
Information
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
covers through Q3 2012
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$660,000 Income
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
covers roughly through Q4, 2012
Lobbying Carried Out by Knight Capitol Consultants
-
Names of Lobbyists
-
Client Amount Genzyme Corp $250,000 Sanofi-Aventis US $240,000 United Natural Products Alliance $160,000 Pharmaceutical Rsrch & Mfrs of America $10,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Fed Budget & Appropriations,
- Copyright, Patent & Trademark,
- Food Industry,
- Law Enforcement & Crime,
- Taxes,
- Medicare & Medicaid,
- Pharmacy,
- Torts,
- Economics & Econ Development
-
Most Frequently Disclosed Bills
Bill No. Title H.R.1364 Free Speech About Science Act of 2011 S.27 Preserve Access to Affordable Generics Act H.R.942 American Research and Competitiveness Act of 2011 H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 H.RES.295 Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease. S.296 Preserving Access to Life-Saving Medications Act S.606 Creating Hope Act of 2011 S.RES.243 A resolution promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease. H.R.2112 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 H.R.3380 Dietary Supplement Protection Act of 2011